Yooma Wellness Inc. (YOOM.CN)
| Previous Close | 0.9600 |
| Open | 0.9600 |
| Bid | 0.9200 x N/A |
| Ask | 1.0000 x N/A |
| Day's Range | 0.9600 - 0.9600 |
| 52 Week Range | 0.8100 - 1.7500 |
| Volume | 7,500 |
| Avg. Volume | 13,599 |
| Market Cap | 72.519M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1240 |
| Earnings Date | May 01, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Yooma Wellness Announces Equity Incentive Grants to Key Personnel
TORONTO, Sept. 06, 2021 (GLOBE NEWSWIRE) -- Yooma Wellness Inc. ("Yooma") (CSE: YOOM, AQSE: YOOM), a Toronto-based vertically-integrated global wellness platform that develops and markets a portfolio of wellness brands, today announced that it has awarded options and deferred share units for an aggregate of 7,355,500 common shares of the company to certain directors, officers, employees and consultants under the Long Term Incentive Plan ("LTIP") approved by the shareholders of Yooma on January 2
- GlobeNewswire
Yooma Wellness Reports Results for Second Quarter of 2021
Second quarter lays the foundation for Yooma’s strategy to become a leading global CBD and wellness platform.TORONTO, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Yooma Wellness Inc. ("Yooma") (CSE: YOOM), a Toronto-based vertically-integrated global wellness platform that develops and markets a portfolio of wellness brands, today released its interim financial statements (the "Financial Statements") for the three-month period ended June 30, 2021 (the "Reporting Period"). A summary of Yooma's operational a
- GlobeNewswire
Yooma Wellness Acquires U.K. Market Leader Vitality CBD
Transaction is part of Yooma’s buy-and-build strategyTORONTO, Aug. 20, 2021 (GLOBE NEWSWIRE) -- Yooma Wellness Inc. ("Yooma" or the "Company") (CSE: YOOM, AQSE: YOOM), a global vertically integrated wellness platform that develops and markets a portfolio of CBD and wellness brands, is pleased to announce it has acquired U.K.-based market leader Vitality CBD Limited (“Vitality”) in a transaction valued at up to £10.2 million (CAD$17.7 million) (the “acquisition”) via the Company’s wholly-owned su
